IP Library Granted Patent US 11,884,928
Granted Patent B2
US 11,884,928 · App. 16/646,013 · Granted Jan 30, 2024

Methods for genetic engineering

Inventor: Yoseph Tsegaye (San Jose, CA)
Assignee: Amyris, Inc.
C12N15/815C07K16/2887C07K16/32C12N9/22C12N15/113C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,884,928
App. No.
16/646,013
Granted
Jan 30, 2024
Kind
B2
Abstract

The invention provides methods for genetically engineering Kluyveromyces . The methods can be used to genetically engineer Kluyveromyces to produce and secrete full-length antibodies or antibody fragments. The invention also provides methods for production and secretion of antibodies.

Claims (13)

1. A method for modifying a target site in a Kluyveromyces host cell genome, the method comprising:

(a) contacting a Kluyveromyces host cell, which has a reduced non-homologous end joining (NHEJ) activity, wherein the NHEJ activity is reduced by integrating a nucleic acid at YKU70 or YKU80, with:

(i) a nuclease capable of cleaving the target site; and

(ii) a donor DNA molecule comprising a nucleic acid sequence encoding a polypeptide, wherein the donor DNA molecule is capable of homologous recombination at the cleaved target site, whereby homologous recombination in the host cell results in integration of the donor linear nucleic acid at the target site;

(b) contacting the host cell with a linear nucleic acid capable of homologous recombination with itself or with one or more additional linear nucleic acids contacted with the host cell, whereby homologous recombination in the host cell converts the linear nucleic acid or the linear nucleic acid and the one or more additional linear nucleic acids into a circular extrachromosomal nucleic acid comprising a coding sequence for a selectable marker; and

(c) selecting a transformed host cell in which the donor DNA molecule is integrated into the target site wherein the host cell secretes the polypeptide encoded by the nucleic acid sequence.

2. The method of claim 1 , wherein the circular extrachromosomal nucleic acid further comprises a stability element derived from K. marxianus.

3. The method of claim 1 , wherein the circular extrachromosomal nucleic acid further comprises a coding sequence for a guide RNA capable of guiding the nuclease to the target site.

4. The method of claim 1 , wherein the nuclease is an RNA-guided DNA endonuclease and the method further comprises introducing into the host cell, during or after step (a), a guide RNA capable of guiding the RNA-guided DNA endonuclease to the target site, wherein the guide RNA is encoded on a plasmid comprising a stability element derived from K. marxianus.

5. The method of claim 1 , wherein the nuclease is an RNA-guided DNA endonuclease and the method further comprises, during or after step (a), contacting the host cell with:

(i) a linear nucleic acid comprising

(1) a nucleic acid sequence encoding a guide RNA capable of guiding the RNA-guided DNA endonuclease to the target site; or

(2) the guide RNA.

Assignments (7)
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2023
From: NAXYRIS S.A.
To: AMYRIS, INC.
Reel/Frame 062760/0753 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
SECURITY INTEREST Recorded Mar 10, 2021
From: AMYRIS, INC., AS GRANTOR
To: NAXYRIS S.A., AS LENDER
Reel/Frame 055547/0529 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2020
From: TSEGAYE, YOSEPH
To: AMYRIS, INC.
Reel/Frame 053169/0157 →